Fibrotic focus in infiltrating ductal carcinoma of the breast: A significant histopathological prognostic parameter for predicting the long-term survival of the patients Takahiro HasebeHitoshi TsudaKiyoshi Mukai OriginalPaper Pages: 195 - 208
Modulating effect of lonidamine on response to doxorubicin in metastatic breast cancer patients: Results from a multicenter prospective randomized trial Dino AmadoriGiovanni Luca FrassinetiWainer Zoli OriginalPaper Pages: 209 - 217
Estrogen receptor negative and progesterone receptor positive primary breast cancer: Pathological characteristics and clinical outcome Agnès BernouxPatricia de CremouxHenri Magdelénat OriginalPaper Pages: 219 - 225
Modulation of estrogen receptor gene expression in human breast cancer cells: A decoy strategy with specific PCR-generated DNA fragments Letizia PenolazziElisabetta LambertiniRoberta Piva OriginalPaper Pages: 227 - 235
High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancers Kun-Huei YehMing-Tseh LinYao-Chang Chen OriginalPaper Pages: 237 - 244
Fractal analysis of mammographic lesions: A prospective, blinded trial Vic Velanovich OriginalPaper Pages: 245 - 249
Evaluation of in vitro chemosensitivity of antitumor drugs using the MTT assay in fresh human breast cancer Jian-Ming XuSan-Tai SongYan Huang OriginalPaper Pages: 251 - 259
ErbB-2 protein in sera and tumors of breast cancer patients Brenda BreuerSteven SmithPaul W. Brandt-Rauf OriginalPaper Pages: 261 - 270